Taken together, these findings highlight the increase of circulating B cells and CD4+ T cells as a specific characteristic of MS among CNS AIDs, for which a reduction in circulating T‐bet+ and CXCR3+ B cells is associated with progressive disease regardless of age. Here, CD4 is linked to myeloid sarcoma.